These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19767159)

  • 21. [Drug therapy of Alzheimer dementia].
    Skausig OB; Laugesem LP; Jensen T
    Ugeskr Laeger; 2003 Jul; 165(29):2899; author reply 2899-900. PubMed ID: 12908363
    [No Abstract]   [Full Text] [Related]  

  • 22. Anti-dementia drugs.
    Allen H
    Int J Geriatr Psychiatry; 1999 Apr; 14(4):239-43. PubMed ID: 10340181
    [No Abstract]   [Full Text] [Related]  

  • 23. NICE proposes to withdraw Alzheimer's drugs from NHS.
    Kmietowicz Z
    BMJ; 2005 Mar; 330(7490):495. PubMed ID: 15746112
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cholinesterase inhibitors in Alzheimer disease: preliminary recommendations for the practice].
    Schölzel-Dorenbos CJ; Jellesma-Eggenkamp MJ
    Ned Tijdschr Geneeskd; 1999 Jan; 143(2):122-3. PubMed ID: 10086120
    [No Abstract]   [Full Text] [Related]  

  • 25. Drugs for Alzheimer's disease and related dementias.
    Gauthier S
    BMJ; 2005 Apr; 330(7496):857-8. PubMed ID: 15831849
    [No Abstract]   [Full Text] [Related]  

  • 26. Medical benefits.
    Iliffe S
    Br J Gen Pract; 2005 Nov; 55(520):886. PubMed ID: 16282015
    [No Abstract]   [Full Text] [Related]  

  • 27. Anticholinesterases in the treatment of Alzheimer's dementia--the first year's experience in Argyll & Clyde.
    Hughes A; Coulter F; Gillespie R; Livingston H; Phillips K; Quinn E; Rimmer E; Smith M; Walker A
    Health Bull (Edinb); 2000 Jan; 58(1):20-4. PubMed ID: 12813848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SIGN guideline for the management of patients with dementia.
    Connelly PJ; James R
    Int J Geriatr Psychiatry; 2006 Jan; 21(1):14-6. PubMed ID: 16353165
    [No Abstract]   [Full Text] [Related]  

  • 29. [Concerning the contribution by Thomas Kaiser, Christiane Florack, Heinrich Franz, Peter Sawicki: donepezil in patients with Alzheimer's dementia. The AD2000 study. Med Klin 2005;100:157-60].
    Vollmar HC; Butzlaff M
    Med Klin (Munich); 2005 Nov; 100(11):771; author reply 771. PubMed ID: 16328187
    [No Abstract]   [Full Text] [Related]  

  • 30. Appeal Court rules that NICE procedure was unfair.
    Dyer C
    BMJ; 2008 May; 336(7652):1035. PubMed ID: 18467392
    [No Abstract]   [Full Text] [Related]  

  • 31. Effectiveness of rivastigmine in Alzheimer's disease. Guidelines do not ignore clinically relevant end points.
    Storosum JG; van Zwieten-Boot BJ; Elferink AJ
    BMJ; 1999 Sep; 319(7210):642. PubMed ID: 10523096
    [No Abstract]   [Full Text] [Related]  

  • 32. NICE judgment: good law risks bad science.
    Bird SM; Matthews F; Muniz G
    Lancet Neurol; 2007 Oct; 6(10):843-4. PubMed ID: 17884668
    [No Abstract]   [Full Text] [Related]  

  • 33. Pressing issues in the dementias and dementia services.
    Holland M
    Hosp Med; 1999 Jul; 60(7):522-4. PubMed ID: 10605547
    [No Abstract]   [Full Text] [Related]  

  • 34. [Present trends in the development of drugs within the cholinesterase inhibitor group as therapeutic agents for Alzheimer's disease].
    Patocka J; Fusek J
    Cesk Psychiatr; 1992 Sep; 88(5):258-69. PubMed ID: 1451205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of acetylcholinesterase inhibitors: diagnosis and severity as predictors of response in routine practice.
    Van Der Putt R; Dineen C; Janes D; Series H; McShane R
    Int J Geriatr Psychiatry; 2006 Aug; 21(8):755-60. PubMed ID: 16906631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. UK government guidance on Alzheimer's drugs postponed.
    O'Neill MF
    Drug Discov Today; 2005 Sep; 10(17):1132. PubMed ID: 16182201
    [No Abstract]   [Full Text] [Related]  

  • 37. Cholinesterase inhibitors for Alzheimer's disease: variations in clinical practice in the north-west of England.
    Purandare N; Swarbrick C; Fischer A; Burns A
    Int J Geriatr Psychiatry; 2006 Oct; 21(10):961-4. PubMed ID: 16927408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of Alzheimer's disease and other dementias.
    Ihl R; Frölich L; Winblad B; Schneider L; Burns A; Möller HJ;
    World J Biol Psychiatry; 2011 Feb; 12(1):2-32. PubMed ID: 21288069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Introduction. Alzheimer's disease: from research to practice.
    Schneider LS
    J Clin Psychiatry; 1998; 59 Suppl 11():3. PubMed ID: 9731542
    [No Abstract]   [Full Text] [Related]  

  • 40. A guide to prescribing anti-dementia medication.
    Kennedy S; Sud D
    Nurs Times; 2014 Jun 4-10; 110(23):16-8. PubMed ID: 25016734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.